Treatment of latent tuberculosis infection and tuberculosis disease
Corporate Authors:National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Tuberculosis Elimination.
Series:Self-study modules on tuberculosis ; module 4
Description:Background -- Objectives -- New Terms --- Treatment of Latent TB Infection (LBTI) -- Treatment of TB Disease -- TB Genotyping -- Additional Resources -- Answers to Study -- Case Study Answers.
In this module, you will learn about the principles of treating latent TB infection (LTBI) and TB disease. A person with LTBI is treated to prevent them from progressing to TB disease. Some people with LTBI are at very high risk of developing TB disease, and they should receive high priority for LTBI treatment. Patients with LTBI who do not complete treatment as prescribed can develop TB disease.
TB disease is treated to cure the patient and to stop the spread of TB. As a health care worker, you may be responsible for ensuring that TB patients take their medications as prescribed. This is very important because patients with TB disease who do not complete treatment as prescribed may become infectious and spread TB to others or develop drug-resistant TB.
This module also explains the possible side effects of the drugs used to treat LTBI and TB disease. If you work with TB patients, you should be aware of the signs and symptoms of these side effects.
Note: The Self-Study Modules on Tuberculosis are a series of educational modules designed to provide information about TB in a self-study format. The target audiences include outreach workers, nurses, physicians, administrators, health educators, and students from a variety of settings. The Modules should not be used as a substitute for guidelines and should not be used for patient care decisions.
Supporting Files:No Additional Files
You May Also Like: